1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-138304 CC-90001

JNK

Inflammation/Immunology

2021-02 CC-90001
HY-126124 AP39

Others

Cardiovascular Disease;

Neurological Disease

2021-02 AP39
HY-137958 AT-527

HCV; SARS-CoV

Infection

2021-02 AT-527
HY-N2381 Menthone

Parasite

Infection;

Inflammation/Immunology

2021-02 Menthone
HY-40136 cis-4-Hydroxy-L-proline

Endogenous Metabolite

Cancer;

Metabolic Disease

2021-02 cis-4-Hydroxy-L-proline
HY-N0523A Gallic acid hydrate

Bacterial

Cancer;

Inflammation/Immunology

2021-02 Gallic acid hydrate
HY-79635 Methyl indole-3-carboxylate

Bacterial

Infection

2021-02 Methyl indole-3-carboxylate
HY-101392 Harmane

Imidazoline Receptor; Monoamine Oxidase; Adrenergic Receptor

Cancer;

Neurological Disease

2021-02 Harmane
HY-Y1125 6-Methyluracil

Endogenous Metabolite

Metabolic Disease

2021-02 6-Methyluracil
HY-137092 IACS-13909

Phosphatase

Cancer

2021-02 IACS-13909
HY-112163A rel-Zotatifin

Eukaryotic Initiation Factor (eIF); SARS-CoV

Cancer;

Infection

2021-02 rel-Zotatifin
HY-138294 RAS/RAS-RAF-IN-1

Ras; Raf

Cancer

2021-02 RAS/RAS-RAF-IN-1
HY-19840 Voxilaprevir

HCV Protease

Infection

2021-02 Voxilaprevir
HY-109187A Posenacaftor sodium

CFTR

Inflammation/Immunology

2021-02 Posenacaftor sodium
HY-138295 KRAS inhibitor-10

Ras

Cancer

2021-02 KRAS inhibitor-10
HY-134539 IMT1

Mitochondrial Metabolism; DNA/RNA Synthesis

Cancer;

Metabolic Disease

2021-02 IMT1
HY-138293 CDK7-IN-3

CDK; Apoptosis

Cancer

2021-02 CDK7-IN-3
HY-107695 Remacemide hydrochloride

iGluR; Sodium Channel

Neurological Disease

2021-02 Remacemide hydrochloride
HY-P3124 BIM-23190

Somatostatin Receptor

Cancer

2021-02 BIM-23190
HY-10570S Nevirapine-D4

HIV; Reverse Transcriptase

Neurological Disease

2021-02 Nevirapine-D4